Glial Fibrillary Acidic Protein
"Glial Fibrillary Acidic Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An intermediate filament protein found only in glial cells or cells of glial origin. MW 51,000.
| Descriptor ID |
D005904
|
| MeSH Number(s) |
D05.750.078.593.400 D12.776.220.475.400
|
| Concept/Terms |
Glial Fibrillary Acidic Protein- Glial Fibrillary Acidic Protein
- Glial Intermediate Filament Protein
- Glial Fibrillary Acid Protein
- Astroprotein
- GFA-Protein
- GFA Protein
|
Below are MeSH descriptors whose meaning is more general than "Glial Fibrillary Acidic Protein".
Below are MeSH descriptors whose meaning is more specific than "Glial Fibrillary Acidic Protein".
This graph shows the total number of publications written about "Glial Fibrillary Acidic Protein" by people in this website by year, and whether "Glial Fibrillary Acidic Protein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 2 | 2 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 2 | 3 |
| 2004 | 1 | 2 | 3 |
| 2005 | 0 | 4 | 4 |
| 2006 | 0 | 2 | 2 |
| 2008 | 0 | 4 | 4 |
| 2009 | 0 | 3 | 3 |
| 2010 | 1 | 3 | 4 |
| 2011 | 0 | 3 | 3 |
| 2012 | 0 | 5 | 5 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 2 | 2 |
| 2015 | 1 | 6 | 7 |
| 2016 | 1 | 1 | 2 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 3 | 3 |
| 2019 | 2 | 1 | 3 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glial Fibrillary Acidic Protein" by people in Profiles.
-
Progesterone Treatment Does Not Decrease Serum Levels of Biomarkers of Glial and Neuronal Cell Injury in Moderate and Severe Traumatic Brain Injury Subjects: A Secondary Analysis of the Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment (ProTECT) III Trial. J Neurotrauma. 2021 07 15; 38(14):1953-1960.
-
Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III. J Neurotrauma. 2019 10 15; 36(20):2863-2871.
-
Association of intraoperative circulating-brain injury biomarker and neurodevelopmental outcomes at 1?year among neonates who have undergone cardiac surgery. J Thorac Cardiovasc Surg. 2019 05; 157(5):1996-2002.
-
Diet-induced insulin resistance elevates hippocampal glutamate as well as VGLUT1 and GFAP expression in A?PP/PS1 mice. J Neurochem. 2019 01; 148(2):219-237.
-
Acute sensitivity of astrocytes in the Substantia Nigra to oxygen and glucose deprivation (OGD) compared with hippocampal astrocytes in brain slices. Neurosci Lett. 2018 10 15; 685:137-143.
-
Chemogenetic Manipulation of Dorsal Hippocampal Astrocytes Protects Against the Development of Stress-enhanced Fear Learning. Neuroscience. 2018 09 15; 388:45-56.
-
Decreased glutathione levels cause overt motor neuron degeneration in hSOD1WT over-expressing mice. Exp Neurol. 2018 04; 302:129-135.
-
Exploring the Role of Astroglial Glutamate Release and Association With Synapses in Neuronal Function and Behavior. Biol Psychiatry. 2018 12 01; 84(11):778-786.
-
Plasma Glial Fibrillary Acidic Protein, Copeptin, and Matrix Metalloproteinase-9 Concentrations among West African Stroke Subjects Compared with Stroke-Free Controls. J Stroke Cerebrovasc Dis. 2018 Mar; 27(3):633-644.
-
Altered glutamate release in the dorsal striatum of the MitoPark mouse model of Parkinson's disease. Brain Res. 2016 11 15; 1651:88-94.